In ovarian cancer, the expression of TAP1 is related to MEF2A, LEF1, while MEF2A can promote tumor cell metastasis by inducing epithelial-mesenchymal transformation and activating Wnt/β-catenin signal pathway (71). Here, MEF2A is linked to ovarian cancer.